Pfizer acquires PowderMed
Clients Pfizer, Inc.
Jones Day represented Pfizer in its acquisition of PowderMed Ltd., a privately held UK company specializing in the development of DNA-based vaccines.
Clients Pfizer, Inc.
Jones Day represented Pfizer in its acquisition of PowderMed Ltd., a privately held UK company specializing in the development of DNA-based vaccines.